Circulating adiponectin levels and the risk of breast cancer: A meta-analysis

European Journal of Cancer Prevention

Volumn 23, Issue 3, 2014, Pages 158-165

  Ye, Jingjing ^a   Jia, Jue ^a   Dong, Sijing ^a   Zhang, Caili ^a   Yu, Shuqin ^a   Li, Lianxi ^b   Mao, Chaoming ^a   Wang, Dong ^a   Chen, Junjian ^a   Yuan, Guoyue ^a  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Adiponectin; Breast cancer; Meta analysis; Risk

Indexed keywords

ADIPONECTIN; ADIPOQ PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER RISK; EMBASE; HUMAN; MEDLINE; OBSERVATIONAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; SCISEARCH; SYSTEMATIC REVIEW; BLOOD; BREAST NEOPLASMS; CASE CONTROL STUDY; FEMALE; META ANALYSIS; RISK FACTOR;

ADIPONECTIN; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; POSTMENOPAUSE; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84897460311     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e328364f293     Document Type: Article

References (36)

1. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. (1999). Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83.
2. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101.
3. Chen DC, Chung YF, Yeh YT, Chaung HC, Kuo FC, Fu OY, et al. (2006). Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett 237:109-114.
4. Conde J, Scotece M, Gómez R, Ló pez V, Gómez-Reino JJ, Lago F, Gualillo O (2011). A complex hub among inflammation, metabolism, and immunity. Biofactors 37:413-420.
5. Dieudonne MN, Bussiere M, Dos Santos E, Leneveu MC, Giudicelli Y, Pecquery R (2006). Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun 345:271-279.
6. Dos Santos E, Benaitreau D, Dieudonne MN, Leneveu MC, Serazin V, Giudicelli Y, Pecquery R (2008). Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells. Oncol Rep 20:971-977.
7. Duggan C, Irwin ML, Xiao L, Henderson KD, Smith AW, Baumgartner RN, et al. (2011). Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J Clin Oncol 29:32-39.
8. Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-Analysis detected by a simple, graphical test. BMJ 315:629-634.
9. Grossmann ME, Ray A, Nkhata KJ, Malakhov DA, Rogozina OP, Dogan S, Cleary MP (2010). Obesity and breast cancer: Status of leptin and adiponectin in pathological processes. Cancer Metastasis Rev 29:641-653.
10. Hou WK, Xu YX, Yu T, Zhang L, Zhang WW, Fu CL, et al. (2007). Adipocytokines and breast cancer risk. Chin Med J (Engl) 120:1592-1596.
11. Jardé T, Caldefie-Ché zet F, Goncalves-Mendes N, Mishellany F, Buechler C, Penault-Llorca F, Vasson MP (2009). Involvement of adiponectin and leptin in breast cancer: Clinical and in vitro studies. Endocr Relat Cancer 16:1197-1210.
12. Jeong YJ, Bong JG, Park SH, Choi JH, Oh HK (2011). Expression of leptin, leptin receptor, adiponectin, and adiponectin receptor in ductal carcinoma in situ and invasive breast cancer. J Breast Cancer 14:96-103.
13. Kaklamani VG, Sadim M, Hsi A, Offit K, Oddoux C, Ostrer H, et al. (2008). Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk. Cancer Res 68:3178-3184.
14. Kang JH, Yu BY, Youn DS (2007). Relationship of serum adiponectin and resistin levels with breast cancer risk. J Korean Med Sci 22:117-121.
15. Kelesidis I, Kelesidis T, Mantzoros CS (2006). Adiponectin and cancer: A systematic review. Br J Cancer 94:1221-1225.
16. Koerner A, Kratzsch J, Kiess W (2005). Adipocytokines: Leptin-The classical, resistin-The controversial, adiponectin-The promising, and more to come. Best Pract Res Clin Endocrinol Metab 19:525-546.
17. Korner A, Pazaitou-Panayiotou K, Kelesidis T, Kelesidis I,Williams CJ, Kaprara A, et al. (2007). Total and high-molecular-weight adiponectin in breast cancer: In vitro and in vivo studies. J Clin Endocrinol Metab 92:1041-1048.
18. Lam JB, Chow KH, Xu A, Lam KS, Liu J, Wong NS, et al. (2009). Adiponectin haploinsufficiency promotes mammary tumor development in MMTV-PyVT mice by modulation of phosphatase and tensin homolog activities. PLoS One 4:e4968.
19. Larsson SC, Mantzoros CS,Wolk A (2007). Diabetes mellitus and risk of breast cancer: A meta-Analysis. Int J Cancer 121:856-862.
20. Lyon CJ, Law RE, Hsueh WA, Chaldakov GN, Stankulov IS, Hristova M, Ghenev PI (2003). Minireview: Adiposity inflammation, and atherogenesis. Endocrinology 144:2195-2200.
21. Mantzoros C, Petridou E, Dessypris N, Chavelas C, Dalamaga M, Alexe DM, et al. (2004). Adiponectin and breast cancer risk. J Clin Endocrinol Metab 89:1102-1107.
22. Mistry T, Digby JE, Desai KM, Randeva HS (2007). Obesity and prostate cancer: A role for adipokines. Eur Urol 52:46-53.
23. Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y, Noguchi S (2003). Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res 9:5699-5704.
24. Pfeiler GH, Buechler C, Neumeier M, Schaffler A, Schmitz G, Ortmann O, Treeck O (2008). Adiponectin effects on human breast cancer cells are dependent on 17-b estradiol. Oncol Rep 19:787-793.
25. Rose DP, Haffner SM, Baillargeon J (2007). Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women. Endocr Rev 28:763-777.
26. Shahar S, Salleh RM, Ghazali AR, Koon PB, Mohamud WN (2010). Roles of adiposity, lifetime physical activity and serum adiponectin in occurrence of breast cancer among Malaysian women in Klang Valley. Asian Pac J Cancer Prev 11:61-66.
27. Shimada K, Miyazaki T, Daida H (2004). Adiponectin and atherosclerotic disease. Clin Chim Acta 344:1-12.
28. Sonnenschein EG, Glickman LT, Goldschmidt MH, McKee LJ (1991). Body conformation, diet, and risk of breast cancer in pet dogs: A case-control study. Am J Epidemiol 133:694-703.
29. Tian YF, Chu CH, Wu MH, Chang CL, Yang T, Chou YC, et al. (2007). Anthropometric measures, plasma adiponectin, and breast cancer risk. Endocr Relat Cancer 14:669-677.
30. Vogel VG (2008). Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer. Menopause 15:782-789.
31. Wang Y, Lam JB, Lam KS, Liu J, Lam MC, Hoo RL, et al. (2006). Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Res 66:11462-11470.
32. Wang Y, Lam KS, Xu A (2007). Adiponectin as a negative regulator in obesityrelated mammary carcinogenesis. Cell Res 17:280-282.
33. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA (2001). Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935.
34. Wolin KY, Carson K, Colditz GA (2010). Obesity and cancer. Oncologist 15:556-565.
35. Youlden DR, Cramb SM, Dunn NAM, Muller JM, Pyke CM, Baade PD (2012). The descriptive epidemiology of female breast cancer: An international comparison of screening, incidence, survival and mortality. Cancer Epidemiol 36:237-248.
36. Zhang BC, Liu WJ, Che LW, Xu YW (2012). Serum total adiponectin level and risk of cardiovascular disease in Han Chinese populations: A meta-Analysis of 17 case-control studies. Clin Endocrinol (Oxf) 77:370-378.